EGFR and cancer: Thus, these studies not only reveal a previously unknown crosstalk between Na,K-ATPase and EGFR signaling, but also suggest that cardiac glycosides might be effective as anticancer therapeutics especially in the more aggressive and invasive cancers associated with aberrant activation of the EGFR signaling cascade.